West Paces Advisors Inc. Seagen Inc. Transaction History

West Paces Advisors Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Dec 18, 2023	BUY	$117.37 - $139.17 $42,253 - $50,101	360 New	360 $46.3 Million
Q1 2018 Dec 21, 2023	SELL	$50.14 - $59.32 $5,014 - $5,932	-100 Reduced 21.74%	360 $18.8 Million
Q4 2017 Dec 21, 2023	SELL	$51.82 - $64.08 $8,809 - $10,893	-170 Reduced 26.98%	460 $24.6 Million
Q3 2017 Dec 21, 2023	BUY	$45.92 - $54.41 $13,776 - $16,322	300 Added 90.91%	630 $34.3 Million
Q1 2017 Dec 21, 2023	SELL	N/A	-30	330 $20.7 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on West Paces Advisors Inc. with notifications on news.